PREVENTING PREMATURE LUTEINISING HORMONE (LH) SURGE 1




Adverse Event reporting information can be found in footer
Request a Meeting
A video which you may find helpful when demonstrating how to use Fyremadel® with your patients
Fyremadel® is supplied in a pre-filled syringe that is ready to use and contains the exact dose for one injection.1
You should only use a Fyremadel® pre-filled syringe once, after which it should be disposed of by placing into a sharps container.
Job Code: UK-FYR-2300004 - Date of preparation: February 2024